McKesson Quarterly Income Statement
NYSE: MCKHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
McKesson revenue and earnings
In the quarter ended Jun 30, 2026, McKesson generated $105.38 billion in revenue, up 7.7% from the same quarter a year earlier. Net income was $614.0 million (-21.7% year over year), for a net margin of 0.6% versus a median of 1.1% in the prior 5 quarters. Gross margin was 3.5% (up from 3.4%) and operating margin 1.3%.
Diluted earnings per share came in at $5.15, down from $6.25.
Summary generated from market data by MetaCap's automated system. Methodology
McKesson income statement (quarterly)
| Quarter (USD) | Q1 20272026-06-30 | Q4 20262026-03-31 | Q3 20262025-12-31 | Q2 20262025-09-30 | Q1 20262025-06-30 | Q4 20252025-03-31 | Q3 20252024-12-31 | Q2 20252024-09-30 | Q1 20252024-06-30 | Q4 20242024-03-31 | Q3 20242023-12-31 | Q2 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 105.38B | 96.30B | 106.16B | 103.15B | 97.83B | 90.82B | 95.29B | 93.65B | 79.28B | 76.36B | 80.90B | 77.22B |
| Revenue growth (YoY) | +7.72% | +6.02% | +11.40% | +10.14% | +23.39% | +18.95% | +17.80% | +21.29% | +6.44% | +10.80% | +14.77% | +10.06% |
| Cost of Revenue | 101.69B | 92.25B | 102.47B | 99.61B | 94.55B | 87.18B | 92.01B | 90.40B | 76.13B | 72.77B | 77.75B | 74.15B |
| Gross Profit | 3.69B | 4.04B | 3.69B | 3.54B | 3.28B | 3.64B | 3.28B | 3.25B | 3.15B | 3.58B | 3.15B | 3.07B |
| Operating Expenses | 2.37B | 1.89B | 2.07B | 2.13B | 2.24B | 2.05B | 2.06B | 2.67B | 2.12B | 2.37B | 2.51B | 2.12B |
| Selling, General & Admin | 2.26B | 1.80B | 2.03B | 2.07B | 2.20B | 1.98B | 2.03B | 2.50B | 2.00B | 2.19B | 2.51B | 2.09B |
| Operating Income | 1.32B | 2.15B | 1.62B | 1.41B | 1.04B | 1.59B | 1.22B | 578.00M | 1.03B | 1.22B | 642.00M | 951.00M |
| Interest Expense | 77.00M | 61.00M | 63.00M | 74.00M | 49.00M | 45.00M | 67.00M | 78.00M | 75.00M | 80.00M | 64.00M | 61.00M |
| Other Income (Expense) | 66.00M | 36.00M | 74.00M | 62.00M | 64.00M | -31.00M | 69.00M | 34.00M | 130.00M | -64.00M | 34.00M | 26.00M |
| Pretax Income | 1.31B | 2.13B | 1.63B | 1.40B | 1.05B | 1.51B | 1.23B | 534.00M | 1.08B | 1.17B | 612.00M | 916.00M |
| Income Tax | 276.00M | 270.00M | 380.00M | 232.00M | 220.00M | 209.00M | 298.00M | 247.00M | 124.00M | 340.00M | -18.00M | 213.00M |
| Net Income | 614.00M | 1.68B | 1.19B | 1.11B | 784.00M | 1.26B | 879.00M | 241.00M | 915.00M | 791.00M | 589.00M | 664.00M |
| Net Income growth (YoY) | -21.68% | +33.49% | +34.93% | +360.58% | -14.32% | +59.29% | +49.24% | -63.70% | -4.49% | +0.51% | -45.41% | -28.29% |
| EPS (Basic) | 5.17 | 13.69 | 9.63 | 8.95 | 6.28 | 9.96 | 6.98 | 1.88 | 7.04 | 6.07 | 4.45 | 4.95 |
| EPS (Diluted) | 5.15 | 13.62 | 9.59 | 8.92 | 6.25 | 9.90 | 6.95 | 1.87 | 7.00 | 6.03 | 4.42 | 4.92 |
| Shares Outstanding (Basic) | 118.70M | — | 123.20M | 124.00M | 124.90M | — | 126.00M | 128.70M | 129.80M | — | 132.50M | 134.10M |
| Shares Outstanding (Diluted) | 119.20M | — | 123.70M | 124.40M | 125.50M | — | 126.60M | 129.30M | 130.70M | — | 133.30M | 134.80M |
| EBITDA | 1.51B | 2.35B | 1.81B | 1.59B | 1.19B | 1.74B | 1.38B | 741.00M | 1.20B | 1.28B | 704.00M | 1.02B |
| Gross Margin | 3.50% | 4.20% | 3.47% | 3.43% | 3.35% | 4.01% | 3.45% | 3.47% | 3.98% | 4.70% | 3.90% | 3.97% |
| Operating Margin | 125.00% | 2.23% | 1.53% | 136.00% | 106.00% | 1.75% | 128.00% | 62.00% | 130.00% | 1.59% | 79.00% | 123.00% |
| Net Margin | 58.00% | 1.75% | 112.00% | 108.00% | 80.00% | 139.00% | 92.00% | 26.00% | 115.00% | 104.00% | 73.00% | 86.00% |
This table shows 12 quarterly periods of McKesson's income statement, from Q1 2027 back to Q2 2024, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow MCK's reporting calendar. What is a income statement?